Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Fraxiparine 2850U°°


Not recommended
unless its is considered to be clearly essential

Not recommended
Lack of data
Fraxiparine 2850U°° :
Type Medicine Withdrawn
Originator Biotech (Fraxiparine 2850U)
Agent Mersaco
Distributor Mersaco
Laboratory Sanofi
Manufacturer Sanofi Winthrop Industrie
Origin France
ATC B01AB06

Your comment will appear shortly after approval

Fraxiparine 2850U°° :

Revision Date : 01/10/2013


Effect Frequency
Anaphylactoid reactions Very rare
Angioedema (Angioneurotic oedema) (Quincke oedema) Very rare
Calcinosis (Tissue calcification) Rare
Eosinophilia Very rare
Erythema Rare
Haemorrhage Very Common
Heparin-induced thrombocytopenia type I Rare
Hyperkalaemia Very rare
Hypersensitivity reactions Very rare
Hypoaldosteronism Very rare
Immune-mediated thrombocytopenia Rare
Injection site haematoma Very Common
Injection site nodule Very Common
Injection site reaction Common
Intraspinal haematoma Very rare
Paralysis Very rare
Priapism Very rare
Pruritus Rare
Skin necrosis Very rare
Skin rash Rare
Skin reaction Very rare
Spinal haematoma Very Common
Thrombocytopenia (Thrombopenia) Rare
Transaminases increased Common
Urticaria Rare

Different Units By MoH Code

Fraxiparine 2850U°°  MoH 2062602 :
Form Solution for injection
Packaging Pre-filled Syringe
Package Size 10x0.3ml
Strength 2850 anti-XaIU
Stratum N/A
NSSF ✘
Quarantine ✘


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info